ISRG as reported
Intuitive Surgical reported $11.0B of revenue over the trailing twelve months, +21% on the year before. 10 reported series are charted on this page, each one as filed.
$11.0B
Revenue, trailing twelve months · to Q2 2026 · +21% against the twelve months before
- Net Income
- $3.14B
Net Income · +20% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $3.22B
Free Cash Flow · +62% year on year · trailing twelve months to Q2 2026
- Op Margin
- 31%
Op Margin · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $11.0B | +21% | Q2 2026 |
| Net Income | $3.14B | +20% | Q2 2026 |
| EPS | $8.72 | +21% | Q2 2026 |
| Gross Margin | 67% | n/a | Q2 2026 |
| Op Margin | 31% | n/a | Q2 2026 |
| Net Margin | 28% | n/a | Q2 2026 |
| ROE | 17% | n/a | Q2 2026 |
| ROA | 15% | n/a | Q2 2026 |
| Free Cash Flow | $3.22B | +62% | Q2 2026 |
| P/E | 42.5 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Intuitive Surgical (ISRG) - Revenue & ProfitRevenue & ProfitIntuitive Surgical (ISRG)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Instruments & Supplies
Ranks #16 of 27 by Smart Score